Literature DB >> 217886

Action of a slowly hydrolysable cyclic AMP analogue on developing cells of Dictyostelium discoideum.

C Rossier, G Gerisch, D Malchow.   

Abstract

Adenosine 3',5'-cyclic phosphorothioate (cAMP-S) is a cyclic AMP (cAMP) analogue which is only slowly hydrolysed by phosphodiesterases of Dictyostelium discoideum. The affinity of cAMP-S to cAMP receptors at the cell surface is only one order of magnitude lower than that of cAMP. cAMP-S can replace cAMP as a stimulant with respect to all receptor-mediated responses tested, including chemotaxis and the induction of cAMP pulses. cAMP-S does not affect growth of D. discoideum but it blocks cell aggregation at a uniform concentration of 5 x 10(-7) M in agar plate cultures of strain NC-4 as well as its axenically growing derivative, Ax-2. Another wild-type strain of D. discoideum, v-12, is able to aggregate on agar plates supplemented with 1 mM cAMP-S. The development of Polysphondylium pallidum and P. violaceum is also highly cAMP-S resistant. In Ax-2 both differentiation from the growth phase to the aggregation-competent stage and chemotaxis are cAMP-S sensitive, whereas in v-12 only chemotaxis is inhibited. v-12 can still form streams of cohering cells and fruiting bodies when chemotaxis is inhibited by cAMP-S. Whereas cAMP induces differentiation into stalk cells at concentrations of 10(-3) or 10(-4) M, cAMP-S has the same effect in strain v-12 at the much lower concentration of 10(-6) M.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 217886     DOI: 10.1242/jcs.35.1.321

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  21 in total

1.  Nucleocytoplasmic shuttling of a GATA transcription factor functions as a development timer.

Authors:  Huaqing Cai; Mariko Katoh-Kurasawa; Tetsuya Muramoto; Balaji Santhanam; Yu Long; Lei Li; Masahiro Ueda; Pablo A Iglesias; Gad Shaulsky; Peter N Devreotes
Journal:  Science       Date:  2014-03-21       Impact factor: 47.728

2.  Conditions that alter intracellular cAMP levels affect expression of the cAMP phosphodiesterase gene in Dictyostelium.

Authors:  B B Riley; S L Barclay
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

3.  A secreted factor and cyclic AMP jointly regulate cell-type-specific gene expression in Dictyostelium discoideum.

Authors:  M C Mehdy; R A Firtel
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

Review 4.  Genetics of early Dictyostelium discoideum development.

Authors:  R H Kessin
Journal:  Microbiol Rev       Date:  1988-03

5.  Differential effects of temperature on cAMP-induced excitation, adaptation, and deadaptation of adenylate and guanylate cyclase in Dictyostelium discoideum.

Authors:  P J Van Haastert
Journal:  J Cell Biol       Date:  1987-11       Impact factor: 10.539

6.  Quantification of motility and area changes of Dictyostelium discoideum amoebae in response to chemoattractants.

Authors:  J E Segall
Journal:  J Muscle Res Cell Motil       Date:  1988-12       Impact factor: 2.698

7.  Osmotic stress response in Dictyostelium is mediated by cAMP.

Authors:  A Ott; F Oehme; H Keller; S C Schuster
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

8.  Cell-substrate interactions and locomotion of Dictyostelium wild-type and mutants defective in three cytoskeletal proteins: a study using quantitative reflection interference contrast microscopy.

Authors:  M Schindl; E Wallraff; B Deubzer; W Witke; G Gerisch; E Sackmann
Journal:  Biophys J       Date:  1995-03       Impact factor: 4.033

9.  Intracellular adenosine 3',5'-phosphate formation is essential for down-regulation of surface adenosine 3',5'-phosphate receptors in Dictyostelium.

Authors:  P J Van Haastert
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

10.  Analogs of cyclic AMP as chemoattractants and inhibitors of Dictyostelium chemotaxis.

Authors:  P J Van Haastert; B Jastorff; J E Pinas; T M Konijn
Journal:  J Bacteriol       Date:  1982-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.